Q9981 – Rolapitant, oral, 1 mg
HCPCS Level II code · Q codes: Temporary Codes
HCPCS codeQ9981
- Long description
- Rolapitant, oral, 1 mg
- Short description
- Rolapitant, oral, 1mg
- Pricing indicator
51Drugs- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1EOther drugs- Cross reference
- J8670
- Added
- July 1, 2016
- Last change
- January 1, 2017 – No change
- Termination date
- December 31, 2016
Frequently asked questions
What is HCPCS code Q9981?
Q9981 is a HCPCS Level II code for rolapitant, oral, 1 mg. It was discontinued on December 31, 2016.
Does Medicare cover Q9981?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby Q codes
- Q9973 – Injection, epoetin beta, 1 microgram, (non-esrd use)
- Q9974 – Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg
- Q9975 – Injection, factor viii fc fusion protein (recombinant), per iu
- Q9976 – Injection, ferric pyrophosphate citrate solution, 0.1 mg of iron
- Q9977 – Compounded drug, not otherwise classified
- Q9978 – Netupitant 300 mg and palonosetron 0.5 mg
- Q9979 – Injection, alemtuzumab, 1 mg
- Q9980 – Hyaluronan or derivative, genvisc 850, for intra-articular injection, 1 mg
- Q9982 – Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries
- Q9983 – Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries
- Q9984 – Levonorgestrel-releasing intrauterine contraceptive system (kyleena), 19.5 mg
- Q9985 – Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg
- Q9986 – Injection, hydroxyprogesterone caproate, (makena), 10 mg
- Q9987 – Pathogen(s) test for platelets
- Q9988 – Platelets, pheresis, pathogen-reduced, each unit
- Q9989 – Ustekinumab, for intravenous injection, 1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.